论文信息 - The influence of KRAS and BRAF mutations on the efficacy of cetuximab‐based first‐line therapy of metastatic colorectal cancer: An analysis of the AIO KRK‐0104‐trial - 字舞流文

The influence of KRAS and BRAF mutations on the efficacy of cetuximab‐based first‐line therapy of metastatic colorectal cancer: An analysis of the AIO KRK‐0104‐trial

C. Giessen | C. Schulz | M. Haas | R. Laubender | N. Moosmann | Dominik Paul Modest | Andreas Jung | Jens Neumann | Stefan Boeck | Thomas Kirchner | Volker Heinemann | S. Stintzing | D. Modest